Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).

Abstract : OBJECTIVES: To assess the efficacy and tolerability of zonisamide in a study allowing flexible dosing in a more diverse and less refractory population than assessed in randomized controlled trials. METHODS: This 19-week, non-comparative study of adjunctive zonisamide included 281 adults who had at least four partial-onset seizures within 8 weeks on one or two antiepileptic drugs. Alterations to zonisamide doses were allowed after titration, except during two fixed-dose periods (weeks 10-13 and 16-19). RESULTS: At the end of the second fixed-dose period (median dose 300 mg/day), the median reduction in monthly seizure frequency was 33.3-41.1%; > or =50% responder rate was 40.9-44.2%; and seizure freedom rate was 15.0-15.9%, depending on the analysis used. The most common adverse events were fatigue (16.7%) and somnolence (15.3%). CONCLUSIONS: Zonisamide demonstrated efficacy in a setting more reflective of clinical practice and was generally well tolerated.
Type de document :
Article dans une revue
Acta Neurologica Scandinavica, Wiley, 2010, 121 (3), pp.141-8. 〈10.1111/j.1600-0404.2009.01311.x〉
Liste complète des métadonnées

https://hal.inria.fr/hal-00795768
Contributeur : Olivier Colliot <>
Soumis le : jeudi 28 février 2013 - 19:48:41
Dernière modification le : jeudi 11 janvier 2018 - 06:25:29

Identifiants

Collections

ICM | UPMC

Citation

Sophie Dupont, S. Striano, E. Trinka, J. Springub, A. T. Giallonardo, et al.. Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).. Acta Neurologica Scandinavica, Wiley, 2010, 121 (3), pp.141-8. 〈10.1111/j.1600-0404.2009.01311.x〉. 〈hal-00795768〉

Partager

Métriques

Consultations de la notice

67